A key figure in Donald Trump's transition team has revealed that Robert F. Kennedy Jr. , a prominent vaccine skeptic, wants access to federal health data. Kennedy believes this data will help him prove that vaccines are unsafe, potentially leading to their removal from the market if Trump returns to the White House. In a CNN interview, Howard Lutnick, CEO of Cantor Fitzgerald, echoed Kennedy's debunked claims about vaccine safety, including the disproven link between vaccines and autism.

While Lutnick didn't specify Kennedy's role, he mentioned Kennedy's desire to reorganize health agencies like the CDC and FDA. Public health experts are concerned that giving Kennedy influence could have serious health consequences, especially for children. Kennedy has said he wants to exercise his influence over a wide range of policies, and Trump has indicated that Kennedy will play a significant role in his administration.

The World Health Organization estimates that vaccines have saved over 154 million lives globally in the past 50 years. Despite this, Kennedy's anti-vaccine stance has raised alarms among public health advocates. They worry that his influence could lead to a resurgence of preventable diseases and waste resources.

Joshua Sharfstein, a former FDA deputy commissioner, warned that giving Kennedy power over health agencies could be extremely dangerous. Even a lesser role for Kennedy could still be damaging, as seen with Trump's former COVID-19 advisor, Scott Atlas.

Kennedy's anti-vaccine organization is currently suing news outlets, including the AP, for identifying misinformation about COVID-19 vaccines. Republican lawmakers have traditionally supported pharmaceutical companies, but vaccine skepticism has grown among conservatives.

Public health advocates are disheartened by the possibility of Kennedy's influence leading to debunked ideas like a vaccine-autism link being resurfaced. Amy Pisani, CEO of Vaccinate Your Family, expressed concern about wasting resources on another anti-vaccine fight.

Trump Ally Wants Vaccine Data to Prove Safety Concerns

Actions